1
|
Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests.
|
Fundam Appl Toxicol
|
1992
|
1.83
|
2
|
Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice.
|
Fundam Appl Toxicol
|
1988
|
1.71
|
3
|
Subchronic 10 day immunotoxicity of polydimethylsiloxane (silicone) fluid, gel and elastomer and polyurethane disks in female B6C3F1 mice.
|
Drug Chem Toxicol
|
1994
|
1.23
|
4
|
Antineoplastic activity of cannabinoids.
|
J Natl Cancer Inst
|
1975
|
1.14
|
5
|
Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide.
|
Fundam Appl Toxicol
|
1993
|
1.07
|
6
|
Molecular regulation of IL-6 activation by asbestos in lung epithelial cells: role of reactive oxygen species.
|
J Immunol
|
1997
|
1.06
|
7
|
Comparison of mouse strains using the local lymph node assay.
|
Toxicology
|
2000
|
1.05
|
8
|
Norepinephrine and the antibody response.
|
Pharmacol Rev
|
1985
|
1.03
|
9
|
Toxicology of chloral hydrate in the mouse.
|
Environ Health Perspect
|
1982
|
1.02
|
10
|
Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus.
|
Infect Immun
|
1979
|
0.99
|
11
|
Biphasic response of the reticuloendothelial system (RES) induced by pyran copolymer.
|
J Reticuloendothel Soc
|
1970
|
0.98
|
12
|
Effect of Tilorone hydrochloride and congeners on reticuloendothelial system, tumors, and the immune response.
|
Cancer Res
|
1972
|
0.96
|
13
|
Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice.
|
Fundam Appl Toxicol
|
1989
|
0.96
|
14
|
Antiviral activity and side effects of polyriboinosinic-cytidylic acid complexes as affected by molecular size.
|
Proc Natl Acad Sci U S A
|
1972
|
0.93
|
15
|
Humoral and cell-mediated immune status in mice exposed to chloral hydrate.
|
Environ Health Perspect
|
1982
|
0.92
|
16
|
Qualitative and quantitative experimental models to aid in risk assessment for immunotoxicology.
|
Toxicol Lett
|
1992
|
0.90
|
17
|
Role of sensitization routes in the development of type I hypersensitivity to natural rubber latex in mice.
|
Am J Ind Med
|
1999
|
0.89
|
18
|
Pyran and polyribonucleotides: differences in biological activities.
|
Antimicrob Agents Chemother
|
1972
|
0.89
|
19
|
An immunotoxicological evaluation of 4,4'-thiobis-(6-t-butyl-m-cresol) in female B6C3F1 mice. 2. Humoral and cell-mediated immunity, macrophage function, and host resistance.
|
Fundam Appl Toxicol
|
1988
|
0.88
|
20
|
Tissue localization studies in evaluating the functional role of the RES.
|
J Reticuloendothel Soc
|
1970
|
0.88
|
21
|
Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro.
|
Cell Immunol
|
1988
|
0.87
|
22
|
The effects of maleic anhydride-divinyl ether (MVE) copolymers on hepatic microsomal mixed-function oxidases and other biologic activities.
|
J Pharmacol Exp Ther
|
1979
|
0.87
|
23
|
Effect of bacterial lipopolysaccharide, lipid A, and concanavalin A on lethality of 5-fluorouracil for mice.
|
Toxicol Appl Pharmacol
|
1975
|
0.87
|
24
|
Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
|
Toxicol Appl Pharmacol
|
2001
|
0.86
|
25
|
Evidence for arsenic as the immunosuppressive component of gallium arsenide.
|
Toxicol Appl Pharmacol
|
1991
|
0.86
|
26
|
Effect of delta 9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig.
|
Proc Soc Exp Biol Med
|
1986
|
0.85
|
27
|
The effect of stimulants and depressants of reticuloendothelial activity on drug metabolism.
|
J Reticuloendothel Soc
|
1971
|
0.85
|
28
|
Immunotoxic effects of diethylstilbestrol on host resistance: comparison with cyclophosphamide.
|
J Leukoc Biol
|
1984
|
0.84
|
29
|
In vitro immunotoxicological assays for detection of compounds requiring metabolic activation.
|
Environ Health Perspect
|
1982
|
0.84
|
30
|
Beta adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro.
|
J Pharmacol Exp Ther
|
1984
|
0.84
|
31
|
Estimation of the median lethal dose when responses within a little are correlated.
|
Biometrics
|
1981
|
0.83
|
32
|
Enhanced susceptibility of mice to combinations of delta 9-tetrahydrocannabinol and live or killed gram-negative bacteria.
|
Infect Immun
|
1977
|
0.83
|
33
|
Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response.
|
Toxicol Appl Pharmacol
|
1991
|
0.83
|
34
|
Immunological responses of mice following administration of natural rubber latex proteins by different routes of exposure.
|
Toxicol Sci
|
2000
|
0.83
|
35
|
A comparison of three nucleoside analogs with anti-retroviral activity on immune and hematopoietic functions in mice: in vitro toxicity to precursor cells and microstromal environment.
|
Toxicol Appl Pharmacol
|
1989
|
0.83
|
36
|
In vitro inhibition of the primary antibody response to sheep erythrocytes by cyclophosphamide.
|
Toxicol Appl Pharmacol
|
1981
|
0.82
|
37
|
Thalidomide stimulates splenic IgM antibody response and cytotoxic T lymphocyte activity and alters leukocyte subpopulation numbers in female B6C3F1 mice.
|
Toxicol Appl Pharmacol
|
2000
|
0.82
|
38
|
Humoral and cell-mediated immune status of mice exposed to trans-1,2-dichloroethylene.
|
Drug Chem Toxicol
|
1985
|
0.82
|
39
|
The toxicity of some halomethanes in mice.
|
Toxicol Appl Pharmacol
|
1978
|
0.81
|
40
|
Effects of hydroxyethylstarch (Hespan), a plasma expander, on the functional activity of the reticuloendothelial system. Comparison with human serum albumin and pyran copolymer.
|
Drug Chem Toxicol
|
1986
|
0.81
|
41
|
Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55).
|
J Pharmacol Exp Ther
|
1993
|
0.81
|
42
|
Effects of delta9-tetrahydrocannabinol in Lewis lung adenocarcinoma cells in tissue culture.
|
J Natl Cancer Inst
|
1976
|
0.81
|
43
|
Humoral and cell-mediated immune status in mice exposed to trichloroethylene in the drinking water.
|
Toxicol Appl Pharmacol
|
1982
|
0.81
|
44
|
Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity.
|
J Pharmacol Exp Ther
|
1978
|
0.81
|
45
|
Glycidol modulation of the immune responses in female B6C3F1 mice.
|
Drug Chem Toxicol
|
2000
|
0.81
|
46
|
In vivo assessment of immunotoxicity.
|
Environ Health Perspect
|
1982
|
0.81
|
47
|
Suppression of splenic accessory cell function in mice exposed to gallium arsenide.
|
Toxicol Appl Pharmacol
|
1991
|
0.81
|
48
|
Lethal interaction of bacterial lipopolysaccharide and naturally occurring cannabinoids.
|
J Reticuloendothel Soc
|
1978
|
0.80
|
49
|
The B lymphocyte is the immune cell target for 2',3'-dideoxyadenosine.
|
Toxicol Appl Pharmacol
|
1990
|
0.80
|
50
|
Relationship of molecular weight to antiviral and antitumor activities and toxic effects of maleic anhydride-divinyl ether (MVE) polyanions.
|
Cancer Treat Rep
|
1978
|
0.80
|
51
|
Experimental studies of the hematologic and immune system toxicity of nucleoside derivatives used against HIV infection.
|
Int J Immunopharmacol
|
1991
|
0.80
|
52
|
Enhanced toxicity for mice of combinations of bacterial lipopolysaccharide and vincristine.
|
Antimicrob Agents Chemother
|
1976
|
0.80
|
53
|
Reversal of gallium arsenide-induced suppression of the antibody response by a mixed disulfide metabolite of meso-2,3-dimercaptosuccinic acid.
|
J Pharmacol Exp Ther
|
1993
|
0.80
|
54
|
Enhanced cytotoxicity in mice of combinations of concanavalin A and selected antitumor drugs.
|
Adv Exp Med Biol
|
1975
|
0.80
|
55
|
Immunotoxicological profile of morphine sulfate in B6C3F1 female mice.
|
Fundam Appl Toxicol
|
1994
|
0.80
|
56
|
Oxymetholone modulates cell-mediated immunity in male B6C3F1 mice.
|
Drug Chem Toxicol
|
2000
|
0.79
|
57
|
The effect of methadone on the immune status of B6C3F1 mice.
|
Fundam Appl Toxicol
|
1995
|
0.79
|
58
|
Assessment of cholinergic influences on a primary humoral immune response.
|
Immunology
|
1992
|
0.79
|
59
|
Immunosuppressive effects of 8,9-epoxyhexahydrocannabinol (EHHC).
|
J Pharmacol Exp Ther
|
1977
|
0.79
|
60
|
Immunotoxicologic studies with CI-959, a novel benzothiophene cell activation inhibitor.
|
Toxicology
|
1995
|
0.79
|
61
|
Immunomodulation of local and systemic immunity after subchronic pulmonary exposure of mice to benzo(a)pyrene.
|
Int J Immunopharmacol
|
1987
|
0.78
|
62
|
Immunosuppressive effects of the Lewis lung carcinoma.
|
J Reticuloendothel Soc
|
1979
|
0.78
|
63
|
Gallium arsenide-induced increase in serum corticosterone is not responsible for suppression of the IgM antibody response.
|
J Pharmacol Exp Ther
|
1994
|
0.78
|
64
|
Immunotoxicological investigations in the mouse: general approach and methods.
|
Drug Chem Toxicol
|
1985
|
0.78
|
65
|
Suppression of cell-mediated immunocompetence after subchronic exposure to diethylstilbestrol in female B6C3F1 mice.
|
J Pharmacol Exp Ther
|
1983
|
0.78
|
66
|
Role of alpha adrenoceptor activation in modulating the murine primary antibody response in vitro.
|
J Pharmacol Exp Ther
|
1985
|
0.78
|
67
|
Contact hypersensitivity response to glutaraldehyde in guinea pigs and mice.
|
Toxicol Ind Health
|
1989
|
0.78
|
68
|
The inhibition of DNA synthesis by cannabinoids.
|
Cancer Res
|
1976
|
0.77
|
69
|
Assessment of the functional integrity of the humoral immune response: the plaque-forming cell assay and the enzyme-linked immunosorbent assay.
|
Methods
|
1999
|
0.77
|
70
|
Immunotoxicity of 180 day exposure to polydimethylsiloxane (silicone) fluid, gel and elastomer and polyurethane disks in female B6C3F1 mice.
|
Drug Chem Toxicol
|
1994
|
0.77
|
71
|
Immunosuppression induced by chemicals requiring metabolic activation in mixed cultures of rat hepatocytes and murine splenocytes.
|
Toxicol Appl Pharmacol
|
1986
|
0.77
|
72
|
Respiratory exposure to diesel exhaust particles decreases the spleen IgM response to a T cell-dependent antigen in female B6C3F1 mice.
|
Toxicol Sci
|
2003
|
0.77
|
73
|
Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. II. Nature and identification of reversing factors.
|
J Pharmacol Exp Ther
|
1993
|
0.76
|
74
|
Direct suppression of cultured spleen cell responses by chlordane and the basis for differential effects on in vivo and in vitro immunocompetence.
|
J Toxicol Environ Health
|
1987
|
0.76
|
75
|
Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation.
|
J Pharmacol Exp Ther
|
1996
|
0.76
|
76
|
An immunotoxicological evaluation of gamma-chlordane.
|
Fundam Appl Toxicol
|
1986
|
0.76
|
77
|
Toxicology of trans-1,2-dichloroethylene in the mouse.
|
Drug Chem Toxicol
|
1985
|
0.76
|
78
|
Immunotoxicological characteristics of sodium methyldithiocarbamate.
|
Fundam Appl Toxicol
|
1992
|
0.76
|
79
|
Immunotoxic effects of diethylstilbestrol (DES) and cadmium chloride (CAD) on host resistance: comparison with cyclophosphamide (CPS).
|
Prog Clin Biol Res
|
1984
|
0.76
|
80
|
Kinetics of the enhancing effect produced by norepinephrine and terbutaline on the murine primary antibody response in vitro.
|
J Pharmacol Exp Ther
|
1984
|
0.76
|
81
|
Toxicology of trichloroethylene in the mouse.
|
Toxicol Appl Pharmacol
|
1982
|
0.76
|
82
|
Immunological evaluation of the mycotoxin patulin in female B6C3F1 mice.
|
Food Chem Toxicol
|
1998
|
0.76
|
83
|
Toxicology of 1,1,2-trichloroethane in the mouse.
|
Drug Chem Toxicol
|
1985
|
0.75
|
84
|
Evaluation of murine splenic cell type metabolism of benzo[a]pyrene and functionality in vitro following repeated in vivo exposure to benzo[a]pyrene.
|
Toxicol Appl Pharmacol
|
1992
|
0.75
|
85
|
Toxicology of organic drinking water contaminants: trichloromethane, bromodichloromethane, dibromochloromethane and tribromomethane.
|
Environ Health Perspect
|
1982
|
0.75
|
86
|
Enhancement of the murine primary antibody response by phenylephrine in vitro.
|
Drug Chem Toxicol
|
1991
|
0.75
|
87
|
Studies on the chemistry, antitumor activity, and pharmacology of ethyl di-(2,2-dimethyl)ethylenamido phosphate (AB-163).
|
J Surg Oncol
|
1969
|
0.75
|
88
|
Modification of the pharmacokinetics of MVE-2 to enhance its effects on host resistance.
|
Prog Clin Biol Res
|
1984
|
0.75
|
89
|
Humoral and cell-mediated immune status of mice exposed to 1,1,2-trichloroethane.
|
Drug Chem Toxicol
|
1985
|
0.75
|
90
|
2'3'-Dideoxyinosine inhibits the humoral immune response in female B6C3F1 mice by targeting the B lymphocyte.
|
Toxicol Appl Pharmacol
|
1997
|
0.75
|
91
|
Polymaleic anhydride: effects on the immune system and Friend leukemia disease of mice.
|
J Reticuloendothel Soc
|
1978
|
0.75
|
92
|
Suppression of the antibody response by phorbol esters in the mouse is due to an effect on the nylon wool adherent cell population.
|
Agents Actions
|
1985
|
0.75
|
93
|
Silicone-induced modulation of natural killer cell activity.
|
Curr Top Microbiol Immunol
|
1996
|
0.75
|
94
|
Antitumor activity of enkephalin analogues in inhibiting PYB6 tumor growth in mice and immunological effects of methionine enkephalinamide.
|
Int J Immunopharmacol
|
1989
|
0.75
|
95
|
Potentiation of cortisone-induced RES suppression in mice by vitamin K 1 .
|
J Reticuloendothel Soc
|
1973
|
0.75
|
96
|
Maleic vinyl ether activation of murine macrophages against lung-metastasizing tumors.
|
Cancer Res
|
1981
|
0.75
|
97
|
Contact hypersensitivity response to o-benzyl-p-chlorophenol in mice.
|
Drug Chem Toxicol
|
1991
|
0.75
|
98
|
Arsenic in the sera of gallium arsenide-exposed mice inhibits bacterial growth and increases host resistance.
|
J Pharmacol Exp Ther
|
1993
|
0.75
|
99
|
Responsiveness of the Madison 109 lung carcinoma to maleic vinyl ether copolymer.
|
J Immunopharmacol
|
1983
|
0.75
|
100
|
Carbon tetrachloride is immunosuppressive and decreases host resistance to Listeria monocytogenes and Streptococcus pneumoniae in female B6C3F1 mice.
|
Toxicology
|
2000
|
0.75
|
101
|
GLP problems from the point of view of the university.
|
J Environ Pathol Toxicol
|
1980
|
0.75
|
102
|
Toxicology and humoral immunity assessment of octamethylcyclotetrasiloxane (D4) following a 28-day whole body vapor inhalation exposure in Fischer 344 rats.
|
Drug Chem Toxicol
|
1999
|
0.75
|
103
|
Effects of CI-949, a novel antiallergy agent, on immune function of male Fischer 344 rats.
|
J Pharmacol Exp Ther
|
1991
|
0.75
|
104
|
Potentiation of the in vitro T-dependent antibody response by the B subunit of cholera toxin.
|
J Pharmacol Exp Ther
|
1987
|
0.75
|
105
|
Immunotoxicity of 2',3'-dideoxyinosine in female B6C3F1 mice.
|
Drug Chem Toxicol
|
1997
|
0.75
|
106
|
Contact hypersensitivity response to isophorone diisocyanate in mice.
|
Drug Chem Toxicol
|
1990
|
0.75
|
107
|
Suppression of the in vitro humoral immune response by chrysotile asbestos.
|
Toxicol Appl Pharmacol
|
1986
|
0.75
|
108
|
Metabolism of benzo[a]pyrene by murine splenic cell types.
|
Toxicol Appl Pharmacol
|
1992
|
0.75
|
109
|
The T-lymphocyte is the primary cellular target for potentiation of the in vitro T-dependent IgM antibody response by the B subunit of cholera toxin.
|
Int J Immunopharmacol
|
1992
|
0.75
|
110
|
Primary cellular target responsible for dimethylnitrosamine-induced immunosuppression in the mouse.
|
Immunopharmacology
|
1987
|
0.75
|
111
|
Generation of 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene by murine splenic macrophages.
|
Toxicol Appl Pharmacol
|
1992
|
0.75
|
112
|
Oncology education: a behavioral approach.
|
J Med Educ
|
1973
|
0.75
|
113
|
In vivo and in vitro effects of sodium azide on mouse complement.
|
Toxicol Appl Pharmacol
|
1984
|
0.75
|
114
|
Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. I. Pharmacokinetics after in vitro and in vivo exposure.
|
J Pharmacol Exp Ther
|
1993
|
0.75
|
115
|
Synergistic lethal action of alkylating agents and sodium pentobarbital in the mouse.
|
Pharmacology
|
1974
|
0.75
|
116
|
Effects of CI-949, a novel antiallergy compound, on host resistance in mice.
|
Fundam Appl Toxicol
|
1991
|
0.75
|
117
|
Hyporesponsiveness to the immunosuppressant effects of delta-8-tetrahydrocannabinol.
|
J Immunopharmacol
|
1982
|
0.75
|
118
|
Hepatic and splenic phagocytosis in female B6C3F1 mice implanted with morphine sulfate pellets.
|
J Pharmacol Exp Ther
|
1993
|
0.75
|
119
|
[Trasylol R on the status of experimental shock (preliminary results)].
|
Rev Bras Med
|
1968
|
0.75
|
120
|
Analysis of gene expression induced by irritant and sensitizing chemicals using oligonucleotide arrays.
|
Int Immunopharmacol
|
2001
|
0.75
|
121
|
Suppression of the in vitro specific antibody response by 12-O-tetradecanoylphorbol-13-acetate (TPA) in the mouse.
|
J Leukoc Biol
|
1984
|
0.75
|
122
|
Preparation and antitumor activity of tris(2,3-dimethyl-1-aziridinyl)phosphine oxide (TEPA-132).
|
Cancer Chemother Rep
|
1967
|
0.75
|
123
|
Acute lethality for mice following administration of cyclophosphamide with barbiturates.
|
Proc Soc Exp Biol Med
|
1973
|
0.75
|
124
|
Role of reactive metabolites in suppression of humoral immunity by N-nitrosodimethylamine.
|
J Pharmacol Exp Ther
|
1987
|
0.75
|
125
|
Dependence on intact cells for the in vitro activation of dimethylnitrosamine to an immunosuppressive form.
|
Mutat Res
|
1987
|
0.75
|
126
|
Pharmacological activity and toxicity of phencyclidine (PCP) and phenylcyclohexene (PC), a pyrolysis product.
|
Life Sci
|
1982
|
0.75
|